nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C8—Simvastatin—atherosclerosis	0.0873	0.12	CbGbCtD
Nilutamide—CYP2C8—Pravastatin—atherosclerosis	0.0854	0.117	CbGbCtD
Nilutamide—CYP2C8—Lovastatin—atherosclerosis	0.0854	0.117	CbGbCtD
Nilutamide—CYP2C19—Rosuvastatin—atherosclerosis	0.0788	0.108	CbGbCtD
Nilutamide—CYP2C19—Simvastatin—atherosclerosis	0.0732	0.101	CbGbCtD
Nilutamide—CYP2C19—Lovastatin—atherosclerosis	0.0716	0.0985	CbGbCtD
Nilutamide—CYP2C9—Rosuvastatin—atherosclerosis	0.0655	0.09	CbGbCtD
Nilutamide—CYP2C9—Simvastatin—atherosclerosis	0.0609	0.0837	CbGbCtD
Nilutamide—CYP2C9—Lovastatin—atherosclerosis	0.0596	0.0819	CbGbCtD
Nilutamide—CYP2C9—Pravastatin—atherosclerosis	0.0596	0.0819	CbGbCtD
Nilutamide—Flutamide—AHR—atherosclerosis	0.00634	0.864	CrCbGaD
Nilutamide—Interstitial lung disease—Ezetimibe—atherosclerosis	0.00313	0.0138	CcSEcCtD
Nilutamide—Interstitial lung disease—Simvastatin—atherosclerosis	0.00299	0.0132	CcSEcCtD
Nilutamide—Cough increased—Rosuvastatin—atherosclerosis	0.00291	0.0129	CcSEcCtD
Nilutamide—Lung disorder—Niacin—atherosclerosis	0.00274	0.0121	CcSEcCtD
Nilutamide—Interstitial lung disease—Pravastatin—atherosclerosis	0.0027	0.0119	CcSEcCtD
Nilutamide—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00239	0.0105	CcSEcCtD
Nilutamide—Cataract—Lovastatin—atherosclerosis	0.00238	0.0105	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.00226	0.00997	CcSEcCtD
Nilutamide—Cataract—Simvastatin—atherosclerosis	0.00222	0.0098	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.00222	0.00978	CcSEcCtD
Nilutamide—Cough increased—Niacin—atherosclerosis	0.00212	0.00935	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.00211	0.00933	CcSEcCtD
Nilutamide—Nocturia—Pravastatin—atherosclerosis	0.00206	0.00909	CcSEcCtD
Nilutamide—Gynaecomastia—Lovastatin—atherosclerosis	0.00202	0.00892	CcSEcCtD
Nilutamide—Cataract—Pravastatin—atherosclerosis	0.00201	0.00886	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.00191	0.00843	CcSEcCtD
Nilutamide—Gynaecomastia—Simvastatin—atherosclerosis	0.00189	0.00834	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00189	0.00832	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00185	0.00816	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00176	0.00778	CcSEcCtD
Nilutamide—Hot flush—Ezetimibe—atherosclerosis	0.00172	0.00759	CcSEcCtD
Nilutamide—Gynaecomastia—Pravastatin—atherosclerosis	0.00171	0.00754	CcSEcCtD
Nilutamide—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00171	0.00752	CcSEcCtD
Nilutamide—Abnormal vision—Niacin—atherosclerosis	0.00169	0.00747	CcSEcCtD
Nilutamide—Arthritis—Lovastatin—atherosclerosis	0.00169	0.00745	CcSEcCtD
Nilutamide—Influenza—Rosuvastatin—atherosclerosis	0.00167	0.00738	CcSEcCtD
Nilutamide—Arthritis—Ezetimibe—atherosclerosis	0.00166	0.0073	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.0016	0.00704	CcSEcCtD
Nilutamide—Arthritis—Simvastatin—atherosclerosis	0.00158	0.00697	CcSEcCtD
Nilutamide—Depression—Rosuvastatin—atherosclerosis	0.00149	0.00656	CcSEcCtD
Nilutamide—Hot flush—Pravastatin—atherosclerosis	0.00148	0.00654	CcSEcCtD
Nilutamide—Menopausal symptoms—Pravastatin—atherosclerosis	0.00147	0.00649	CcSEcCtD
Nilutamide—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00145	0.0064	CcSEcCtD
Nilutamide—Arthritis—Niacin—atherosclerosis	0.00145	0.0064	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00145	0.00639	CcSEcCtD
Nilutamide—Arthritis—Pravastatin—atherosclerosis	0.00143	0.0063	CcSEcCtD
Nilutamide—Haematuria—Rosuvastatin—atherosclerosis	0.00142	0.00628	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00142	0.00626	CcSEcCtD
Nilutamide—Influenza—Lovastatin—atherosclerosis	0.00142	0.00626	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00141	0.00622	CcSEcCtD
Nilutamide—Disturbance in sexual arousal—Niacin—atherosclerosis	0.0014	0.00617	CcSEcCtD
Nilutamide—Influenza—Ezetimibe—atherosclerosis	0.00139	0.00614	CcSEcCtD
Nilutamide—Rhinitis—Rosuvastatin—atherosclerosis	0.00134	0.00592	CcSEcCtD
Nilutamide—Erectile dysfunction—Lovastatin—atherosclerosis	0.00131	0.00576	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00129	0.0057	CcSEcCtD
Nilutamide—Dry skin—Niacin—atherosclerosis	0.00129	0.0057	CcSEcCtD
Nilutamide—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00128	0.00565	CcSEcCtD
Nilutamide—Dry skin—Pravastatin—atherosclerosis	0.00127	0.00561	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00123	0.00544	CcSEcCtD
Nilutamide—Urinary tract infection—Lovastatin—atherosclerosis	0.00123	0.00542	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00122	0.0054	CcSEcCtD
Nilutamide—Erectile dysfunction—Simvastatin—atherosclerosis	0.00122	0.00539	CcSEcCtD
Nilutamide—Influenza—Niacin—atherosclerosis	0.00122	0.00537	CcSEcCtD
Nilutamide—Influenza—Pravastatin—atherosclerosis	0.0012	0.00529	CcSEcCtD
Nilutamide—Angina pectoris—Niacin—atherosclerosis	0.00119	0.00523	CcSEcCtD
Nilutamide—Depression—Simvastatin—atherosclerosis	0.00118	0.0052	CcSEcCtD
Nilutamide—Angina pectoris—Pravastatin—atherosclerosis	0.00117	0.00515	CcSEcCtD
Nilutamide—Erectile dysfunction—Niacin—atherosclerosis	0.00112	0.00495	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00111	0.00492	CcSEcCtD
Nilutamide—Erectile dysfunction—Pravastatin—atherosclerosis	0.0011	0.00487	CcSEcCtD
Nilutamide—Oedema peripheral—Ezetimibe—atherosclerosis	0.0011	0.00484	CcSEcCtD
Nilutamide—Weight decreased—Pravastatin—atherosclerosis	0.00109	0.00479	CcSEcCtD
Nilutamide—Depression—Pravastatin—atherosclerosis	0.00107	0.0047	CcSEcCtD
Nilutamide—Sweating—Niacin—atherosclerosis	0.00104	0.00459	CcSEcCtD
Nilutamide—Urinary tract infection—Pravastatin—atherosclerosis	0.00104	0.00458	CcSEcCtD
Nilutamide—Cough—Rosuvastatin—atherosclerosis	0.00102	0.00449	CcSEcCtD
Nilutamide—Alopecia—Lovastatin—atherosclerosis	0.001	0.00442	CcSEcCtD
Nilutamide—Enzalutamide—ALB—atherosclerosis	0.001	0.136	CrCbGaD
Nilutamide—Alopecia—Ezetimibe—atherosclerosis	0.000984	0.00434	CcSEcCtD
Nilutamide—Rhinitis—Niacin—atherosclerosis	0.000978	0.00431	CcSEcCtD
Nilutamide—Hypoaesthesia—Niacin—atherosclerosis	0.00097	0.00428	CcSEcCtD
Nilutamide—Rhinitis—Pravastatin—atherosclerosis	0.000963	0.00424	CcSEcCtD
Nilutamide—Oedema peripheral—Niacin—atherosclerosis	0.000961	0.00424	CcSEcCtD
Nilutamide—Back pain—Lovastatin—atherosclerosis	0.000956	0.00422	CcSEcCtD
Nilutamide—Hypoaesthesia—Pravastatin—atherosclerosis	0.000955	0.00421	CcSEcCtD
Nilutamide—Visual impairment—Niacin—atherosclerosis	0.00094	0.00414	CcSEcCtD
Nilutamide—Alopecia—Simvastatin—atherosclerosis	0.000938	0.00414	CcSEcCtD
Nilutamide—Back pain—Ezetimibe—atherosclerosis	0.000938	0.00414	CcSEcCtD
Nilutamide—Visual impairment—Pravastatin—atherosclerosis	0.000925	0.00408	CcSEcCtD
Nilutamide—Ill-defined disorder—Lovastatin—atherosclerosis	0.000917	0.00404	CcSEcCtD
Nilutamide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000899	0.00397	CcSEcCtD
Nilutamide—Anaemia—Ezetimibe—atherosclerosis	0.000896	0.00395	CcSEcCtD
Nilutamide—Malaise—Lovastatin—atherosclerosis	0.000891	0.00393	CcSEcCtD
Nilutamide—Leukopenia—Lovastatin—atherosclerosis	0.000885	0.0039	CcSEcCtD
Nilutamide—Malaise—Ezetimibe—atherosclerosis	0.000874	0.00386	CcSEcCtD
Nilutamide—Alopecia—Niacin—atherosclerosis	0.000862	0.0038	CcSEcCtD
Nilutamide—Insomnia—Rosuvastatin—atherosclerosis	0.000861	0.0038	CcSEcCtD
Nilutamide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000858	0.00378	CcSEcCtD
Nilutamide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000855	0.00377	CcSEcCtD
Nilutamide—Anaemia—Simvastatin—atherosclerosis	0.000854	0.00377	CcSEcCtD
Nilutamide—Alopecia—Pravastatin—atherosclerosis	0.000848	0.00374	CcSEcCtD
Nilutamide—Cough—Ezetimibe—atherosclerosis	0.000846	0.00373	CcSEcCtD
Nilutamide—Chest pain—Lovastatin—atherosclerosis	0.000841	0.00371	CcSEcCtD
Nilutamide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000838	0.00369	CcSEcCtD
Nilutamide—Hypertension—Ezetimibe—atherosclerosis	0.000837	0.00369	CcSEcCtD
Nilutamide—Malaise—Simvastatin—atherosclerosis	0.000834	0.00368	CcSEcCtD
Nilutamide—Tension—Niacin—atherosclerosis	0.000833	0.00367	CcSEcCtD
Nilutamide—Discomfort—Lovastatin—atherosclerosis	0.000831	0.00367	CcSEcCtD
Nilutamide—Leukopenia—Simvastatin—atherosclerosis	0.000828	0.00365	CcSEcCtD
Nilutamide—Chest pain—Ezetimibe—atherosclerosis	0.000825	0.00364	CcSEcCtD
Nilutamide—Nervousness—Niacin—atherosclerosis	0.000824	0.00364	CcSEcCtD
Nilutamide—Dry mouth—Lovastatin—atherosclerosis	0.000823	0.00363	CcSEcCtD
Nilutamide—Tension—Pravastatin—atherosclerosis	0.00082	0.00362	CcSEcCtD
Nilutamide—Discomfort—Ezetimibe—atherosclerosis	0.000815	0.0036	CcSEcCtD
Nilutamide—Pain—Rosuvastatin—atherosclerosis	0.000814	0.00359	CcSEcCtD
Nilutamide—Constipation—Rosuvastatin—atherosclerosis	0.000814	0.00359	CcSEcCtD
Nilutamide—Nervousness—Pravastatin—atherosclerosis	0.000812	0.00358	CcSEcCtD
Nilutamide—Dry mouth—Ezetimibe—atherosclerosis	0.000807	0.00356	CcSEcCtD
Nilutamide—Chest pain—Simvastatin—atherosclerosis	0.000787	0.00347	CcSEcCtD
Nilutamide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000784	0.00346	CcSEcCtD
Nilutamide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000778	0.00343	CcSEcCtD
Nilutamide—Discomfort—Simvastatin—atherosclerosis	0.000778	0.00343	CcSEcCtD
Nilutamide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000775	0.00342	CcSEcCtD
Nilutamide—Anaemia—Pravastatin—atherosclerosis	0.000772	0.00341	CcSEcCtD
Nilutamide—Anorexia—Lovastatin—atherosclerosis	0.000769	0.00339	CcSEcCtD
Nilutamide—Syncope—Niacin—atherosclerosis	0.000761	0.00336	CcSEcCtD
Nilutamide—Leukopenia—Niacin—atherosclerosis	0.00076	0.00335	CcSEcCtD
Nilutamide—Oedema—Simvastatin—atherosclerosis	0.000754	0.00333	CcSEcCtD
Nilutamide—Malaise—Pravastatin—atherosclerosis	0.000754	0.00332	CcSEcCtD
Nilutamide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000752	0.00332	CcSEcCtD
Nilutamide—Leukopenia—Pravastatin—atherosclerosis	0.000748	0.0033	CcSEcCtD
Nilutamide—Loss of consciousness—Niacin—atherosclerosis	0.000746	0.00329	CcSEcCtD
Nilutamide—Cough—Niacin—atherosclerosis	0.000741	0.00327	CcSEcCtD
Nilutamide—Insomnia—Lovastatin—atherosclerosis	0.00073	0.00322	CcSEcCtD
Nilutamide—Cough—Pravastatin—atherosclerosis	0.000729	0.00322	CcSEcCtD
Nilutamide—Paraesthesia—Lovastatin—atherosclerosis	0.000724	0.00319	CcSEcCtD
Nilutamide—Hypertension—Pravastatin—atherosclerosis	0.000722	0.00318	CcSEcCtD
Nilutamide—Anorexia—Simvastatin—atherosclerosis	0.000719	0.00317	CcSEcCtD
Nilutamide—Dyspnoea—Lovastatin—atherosclerosis	0.000719	0.00317	CcSEcCtD
Nilutamide—Insomnia—Ezetimibe—atherosclerosis	0.000716	0.00316	CcSEcCtD
Nilutamide—Chest pain—Pravastatin—atherosclerosis	0.000712	0.00314	CcSEcCtD
Nilutamide—Paraesthesia—Ezetimibe—atherosclerosis	0.00071	0.00313	CcSEcCtD
Nilutamide—Dyspepsia—Lovastatin—atherosclerosis	0.00071	0.00313	CcSEcCtD
Nilutamide—Dry mouth—Niacin—atherosclerosis	0.000707	0.00312	CcSEcCtD
Nilutamide—Dyspnoea—Ezetimibe—atherosclerosis	0.000705	0.00311	CcSEcCtD
Nilutamide—Discomfort—Pravastatin—atherosclerosis	0.000703	0.0031	CcSEcCtD
Nilutamide—Decreased appetite—Lovastatin—atherosclerosis	0.000701	0.00309	CcSEcCtD
Nilutamide—Dyspepsia—Ezetimibe—atherosclerosis	0.000696	0.00307	CcSEcCtD
Nilutamide—Oedema—Niacin—atherosclerosis	0.000693	0.00306	CcSEcCtD
Nilutamide—Constipation—Lovastatin—atherosclerosis	0.00069	0.00304	CcSEcCtD
Nilutamide—Pain—Lovastatin—atherosclerosis	0.00069	0.00304	CcSEcCtD
Nilutamide—Decreased appetite—Ezetimibe—atherosclerosis	0.000688	0.00303	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000683	0.00301	CcSEcCtD
Nilutamide—Asthenia—Rosuvastatin—atherosclerosis	0.000683	0.00301	CcSEcCtD
Nilutamide—Insomnia—Simvastatin—atherosclerosis	0.000682	0.00301	CcSEcCtD
Nilutamide—Oedema—Pravastatin—atherosclerosis	0.000682	0.00301	CcSEcCtD
Nilutamide—Shock—Niacin—atherosclerosis	0.000682	0.00301	CcSEcCtD
Nilutamide—Paraesthesia—Simvastatin—atherosclerosis	0.000677	0.00299	CcSEcCtD
Nilutamide—Pain—Ezetimibe—atherosclerosis	0.000677	0.00298	CcSEcCtD
Nilutamide—Constipation—Ezetimibe—atherosclerosis	0.000677	0.00298	CcSEcCtD
Nilutamide—Pruritus—Rosuvastatin—atherosclerosis	0.000673	0.00297	CcSEcCtD
Nilutamide—Dyspnoea—Simvastatin—atherosclerosis	0.000673	0.00297	CcSEcCtD
Nilutamide—Hyperhidrosis—Niacin—atherosclerosis	0.00067	0.00295	CcSEcCtD
Nilutamide—Feeling abnormal—Lovastatin—atherosclerosis	0.000665	0.00293	CcSEcCtD
Nilutamide—Dyspepsia—Simvastatin—atherosclerosis	0.000664	0.00293	CcSEcCtD
Nilutamide—Anorexia—Niacin—atherosclerosis	0.00066	0.00291	CcSEcCtD
Nilutamide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00066	0.00291	CcSEcCtD
Nilutamide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000659	0.00291	CcSEcCtD
Nilutamide—Decreased appetite—Simvastatin—atherosclerosis	0.000656	0.00289	CcSEcCtD
Nilutamide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000652	0.00288	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000651	0.00287	CcSEcCtD
Nilutamide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000651	0.00287	CcSEcCtD
Nilutamide—Anorexia—Pravastatin—atherosclerosis	0.00065	0.00287	CcSEcCtD
Nilutamide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000647	0.00285	CcSEcCtD
Nilutamide—Pain—Simvastatin—atherosclerosis	0.000645	0.00285	CcSEcCtD
Nilutamide—Constipation—Simvastatin—atherosclerosis	0.000645	0.00285	CcSEcCtD
Nilutamide—Abdominal pain—Lovastatin—atherosclerosis	0.000638	0.00281	CcSEcCtD
Nilutamide—Body temperature increased—Lovastatin—atherosclerosis	0.000638	0.00281	CcSEcCtD
Nilutamide—Dizziness—Rosuvastatin—atherosclerosis	0.000629	0.00278	CcSEcCtD
Nilutamide—Insomnia—Niacin—atherosclerosis	0.000627	0.00276	CcSEcCtD
Nilutamide—Abdominal pain—Ezetimibe—atherosclerosis	0.000625	0.00276	CcSEcCtD
Nilutamide—Body temperature increased—Ezetimibe—atherosclerosis	0.000625	0.00276	CcSEcCtD
Nilutamide—Paraesthesia—Niacin—atherosclerosis	0.000622	0.00274	CcSEcCtD
Nilutamide—Feeling abnormal—Simvastatin—atherosclerosis	0.000622	0.00274	CcSEcCtD
Nilutamide—Dyspnoea—Niacin—atherosclerosis	0.000618	0.00272	CcSEcCtD
Nilutamide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000617	0.00272	CcSEcCtD
Nilutamide—Insomnia—Pravastatin—atherosclerosis	0.000617	0.00272	CcSEcCtD
Nilutamide—Paraesthesia—Pravastatin—atherosclerosis	0.000613	0.0027	CcSEcCtD
Nilutamide—Dyspepsia—Niacin—atherosclerosis	0.00061	0.00269	CcSEcCtD
Nilutamide—Dyspnoea—Pravastatin—atherosclerosis	0.000608	0.00268	CcSEcCtD
Nilutamide—Decreased appetite—Niacin—atherosclerosis	0.000602	0.00266	CcSEcCtD
Nilutamide—Dyspepsia—Pravastatin—atherosclerosis	0.0006	0.00265	CcSEcCtD
Nilutamide—Rash—Rosuvastatin—atherosclerosis	0.0006	0.00265	CcSEcCtD
Nilutamide—Dermatitis—Rosuvastatin—atherosclerosis	0.0006	0.00264	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000598	0.00264	CcSEcCtD
Nilutamide—Body temperature increased—Simvastatin—atherosclerosis	0.000596	0.00263	CcSEcCtD
Nilutamide—Abdominal pain—Simvastatin—atherosclerosis	0.000596	0.00263	CcSEcCtD
Nilutamide—Headache—Rosuvastatin—atherosclerosis	0.000596	0.00263	CcSEcCtD
Nilutamide—Decreased appetite—Pravastatin—atherosclerosis	0.000593	0.00261	CcSEcCtD
Nilutamide—Pain—Niacin—atherosclerosis	0.000592	0.00261	CcSEcCtD
Nilutamide—Pain—Pravastatin—atherosclerosis	0.000583	0.00257	CcSEcCtD
Nilutamide—Constipation—Pravastatin—atherosclerosis	0.000583	0.00257	CcSEcCtD
Nilutamide—Asthenia—Lovastatin—atherosclerosis	0.000579	0.00255	CcSEcCtD
Nilutamide—Pruritus—Lovastatin—atherosclerosis	0.000571	0.00252	CcSEcCtD
Nilutamide—Asthenia—Ezetimibe—atherosclerosis	0.000568	0.0025	CcSEcCtD
Nilutamide—Gastrointestinal pain—Niacin—atherosclerosis	0.000567	0.0025	CcSEcCtD
Nilutamide—Nausea—Rosuvastatin—atherosclerosis	0.000565	0.00249	CcSEcCtD
Nilutamide—Feeling abnormal—Pravastatin—atherosclerosis	0.000562	0.00248	CcSEcCtD
Nilutamide—Pruritus—Ezetimibe—atherosclerosis	0.00056	0.00247	CcSEcCtD
Nilutamide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000558	0.00246	CcSEcCtD
Nilutamide—Diarrhoea—Lovastatin—atherosclerosis	0.000552	0.00243	CcSEcCtD
Nilutamide—Body temperature increased—Niacin—atherosclerosis	0.000548	0.00242	CcSEcCtD
Nilutamide—Abdominal pain—Niacin—atherosclerosis	0.000548	0.00242	CcSEcCtD
Nilutamide—Asthenia—Simvastatin—atherosclerosis	0.000541	0.00239	CcSEcCtD
Nilutamide—Diarrhoea—Ezetimibe—atherosclerosis	0.000541	0.00239	CcSEcCtD
Nilutamide—Body temperature increased—Pravastatin—atherosclerosis	0.000539	0.00238	CcSEcCtD
Nilutamide—Abdominal pain—Pravastatin—atherosclerosis	0.000539	0.00238	CcSEcCtD
Nilutamide—Pruritus—Simvastatin—atherosclerosis	0.000534	0.00235	CcSEcCtD
Nilutamide—Dizziness—Lovastatin—atherosclerosis	0.000533	0.00235	CcSEcCtD
Nilutamide—Dizziness—Ezetimibe—atherosclerosis	0.000523	0.00231	CcSEcCtD
Nilutamide—Diarrhoea—Simvastatin—atherosclerosis	0.000516	0.00228	CcSEcCtD
Nilutamide—Vomiting—Lovastatin—atherosclerosis	0.000513	0.00226	CcSEcCtD
Nilutamide—Rash—Lovastatin—atherosclerosis	0.000509	0.00224	CcSEcCtD
Nilutamide—Dermatitis—Lovastatin—atherosclerosis	0.000508	0.00224	CcSEcCtD
Nilutamide—Headache—Lovastatin—atherosclerosis	0.000505	0.00223	CcSEcCtD
Nilutamide—Vomiting—Ezetimibe—atherosclerosis	0.000503	0.00222	CcSEcCtD
Nilutamide—Dizziness—Simvastatin—atherosclerosis	0.000499	0.0022	CcSEcCtD
Nilutamide—Rash—Ezetimibe—atherosclerosis	0.000499	0.0022	CcSEcCtD
Nilutamide—Dermatitis—Ezetimibe—atherosclerosis	0.000498	0.0022	CcSEcCtD
Nilutamide—Asthenia—Niacin—atherosclerosis	0.000497	0.00219	CcSEcCtD
Nilutamide—Headache—Ezetimibe—atherosclerosis	0.000496	0.00219	CcSEcCtD
Nilutamide—Pruritus—Niacin—atherosclerosis	0.00049	0.00216	CcSEcCtD
Nilutamide—Asthenia—Pravastatin—atherosclerosis	0.000489	0.00216	CcSEcCtD
Nilutamide—Pruritus—Pravastatin—atherosclerosis	0.000483	0.00213	CcSEcCtD
Nilutamide—Vomiting—Simvastatin—atherosclerosis	0.00048	0.00212	CcSEcCtD
Nilutamide—Nausea—Lovastatin—atherosclerosis	0.000479	0.00211	CcSEcCtD
Nilutamide—Rash—Simvastatin—atherosclerosis	0.000476	0.0021	CcSEcCtD
Nilutamide—Dermatitis—Simvastatin—atherosclerosis	0.000475	0.0021	CcSEcCtD
Nilutamide—Diarrhoea—Niacin—atherosclerosis	0.000474	0.00209	CcSEcCtD
Nilutamide—Headache—Simvastatin—atherosclerosis	0.000473	0.00208	CcSEcCtD
Nilutamide—Nausea—Ezetimibe—atherosclerosis	0.00047	0.00207	CcSEcCtD
Nilutamide—Diarrhoea—Pravastatin—atherosclerosis	0.000467	0.00206	CcSEcCtD
Nilutamide—Dizziness—Niacin—atherosclerosis	0.000458	0.00202	CcSEcCtD
Nilutamide—Dizziness—Pravastatin—atherosclerosis	0.000451	0.00199	CcSEcCtD
Nilutamide—Nausea—Simvastatin—atherosclerosis	0.000448	0.00198	CcSEcCtD
Nilutamide—Vomiting—Niacin—atherosclerosis	0.00044	0.00194	CcSEcCtD
Nilutamide—Rash—Niacin—atherosclerosis	0.000437	0.00193	CcSEcCtD
Nilutamide—Dermatitis—Niacin—atherosclerosis	0.000436	0.00192	CcSEcCtD
Nilutamide—Headache—Niacin—atherosclerosis	0.000434	0.00191	CcSEcCtD
Nilutamide—Vomiting—Pravastatin—atherosclerosis	0.000434	0.00191	CcSEcCtD
Nilutamide—Rash—Pravastatin—atherosclerosis	0.00043	0.0019	CcSEcCtD
Nilutamide—Dermatitis—Pravastatin—atherosclerosis	0.00043	0.00189	CcSEcCtD
Nilutamide—Headache—Pravastatin—atherosclerosis	0.000427	0.00188	CcSEcCtD
Nilutamide—Nausea—Niacin—atherosclerosis	0.000412	0.00181	CcSEcCtD
Nilutamide—Nausea—Pravastatin—atherosclerosis	0.000405	0.00179	CcSEcCtD
Nilutamide—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	5.05e-05	0.0013	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	4.99e-05	0.00129	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	4.98e-05	0.00128	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.97e-05	0.00128	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	4.87e-05	0.00126	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	4.87e-05	0.00126	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	4.82e-05	0.00124	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	4.78e-05	0.00123	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	4.76e-05	0.00123	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—ESR1—atherosclerosis	4.76e-05	0.00123	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	4.7e-05	0.00121	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.64e-05	0.0012	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	4.62e-05	0.00119	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	4.51e-05	0.00116	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	4.51e-05	0.00116	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	4.51e-05	0.00116	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	4.51e-05	0.00116	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HSPA1B—atherosclerosis	4.48e-05	0.00115	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	4.46e-05	0.00115	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	4.45e-05	0.00115	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL6—atherosclerosis	4.4e-05	0.00114	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LDLRAP1—atherosclerosis	4.4e-05	0.00113	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—PPARG—atherosclerosis	4.34e-05	0.00112	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	4.34e-05	0.00112	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	4.31e-05	0.00111	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	4.3e-05	0.00111	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	4.17e-05	0.00108	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLTP—atherosclerosis	4.14e-05	0.00107	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	4.13e-05	0.00106	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	4.11e-05	0.00106	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	4.11e-05	0.00106	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	4.11e-05	0.00106	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	4.11e-05	0.00106	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	4.06e-05	0.00105	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PARP1—atherosclerosis	3.99e-05	0.00103	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.97e-05	0.00102	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LDLRAP1—atherosclerosis	3.93e-05	0.00101	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	3.93e-05	0.00101	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—SERPINE1—atherosclerosis	3.91e-05	0.00101	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.84e-05	0.00099	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.83e-05	0.000988	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.81e-05	0.000982	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.78e-05	0.000976	CbGpPWpGaD
Nilutamide—AR—Gene Expression—ESR2—atherosclerosis	3.78e-05	0.000974	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	3.76e-05	0.000971	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.7e-05	0.000954	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLTP—atherosclerosis	3.69e-05	0.000952	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.62e-05	0.000934	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCG8—atherosclerosis	3.59e-05	0.000925	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LTA4H—atherosclerosis	3.59e-05	0.000925	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	3.58e-05	0.000923	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	3.54e-05	0.000913	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.5e-05	0.000902	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.46e-05	0.000891	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.42e-05	0.000882	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.4e-05	0.000877	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.38e-05	0.000871	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLTP—atherosclerosis	3.37e-05	0.000868	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.34e-05	0.000862	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.3e-05	0.000851	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LTA4H—atherosclerosis	3.2e-05	0.000826	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCG8—atherosclerosis	3.2e-05	0.000826	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	3.16e-05	0.000815	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.12e-05	0.000804	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.1e-05	0.000799	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.08e-05	0.000795	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SIRT1—atherosclerosis	3.04e-05	0.000785	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.01e-05	0.000776	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.98e-05	0.00077	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.98e-05	0.000769	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCG8—atherosclerosis	2.92e-05	0.000753	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LTA4H—atherosclerosis	2.92e-05	0.000753	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.88e-05	0.000743	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCG1—atherosclerosis	2.83e-05	0.000731	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.72e-05	0.000702	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—FABP4—atherosclerosis	2.66e-05	0.000687	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LCAT—atherosclerosis	2.66e-05	0.000687	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.66e-05	0.000686	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA4—atherosclerosis	2.62e-05	0.000675	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP7A1—atherosclerosis	2.57e-05	0.000663	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCG1—atherosclerosis	2.53e-05	0.000653	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARA—atherosclerosis	2.53e-05	0.000652	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.45e-05	0.000632	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.43e-05	0.000626	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LCAT—atherosclerosis	2.38e-05	0.000614	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—FABP4—atherosclerosis	2.38e-05	0.000614	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP27A1—atherosclerosis	2.38e-05	0.000613	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.34e-05	0.000603	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA4—atherosclerosis	2.33e-05	0.000602	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCG1—atherosclerosis	2.31e-05	0.000595	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP7A1—atherosclerosis	2.29e-05	0.000592	CbGpPWpGaD
Nilutamide—AR—Gene Expression—ESR1—atherosclerosis	2.29e-05	0.000591	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.28e-05	0.000588	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA2—atherosclerosis	2.25e-05	0.000581	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	2.25e-05	0.000581	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	2.25e-05	0.000581	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALOX15—atherosclerosis	2.25e-05	0.000581	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCG5—atherosclerosis	2.22e-05	0.000574	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.22e-05	0.000573	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.19e-05	0.000564	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—FABP4—atherosclerosis	2.17e-05	0.000559	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LCAT—atherosclerosis	2.17e-05	0.000559	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LPA—atherosclerosis	2.15e-05	0.000554	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA4—atherosclerosis	2.13e-05	0.000549	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP27A1—atherosclerosis	2.12e-05	0.000547	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP7A1—atherosclerosis	2.09e-05	0.000539	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARG—atherosclerosis	2.09e-05	0.000539	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.09e-05	0.000538	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—BGN—atherosclerosis	2.08e-05	0.000537	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.07e-05	0.000533	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA5—atherosclerosis	2.06e-05	0.000531	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.04e-05	0.000525	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	2.01e-05	0.000518	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA2—atherosclerosis	2.01e-05	0.000518	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	2.01e-05	0.000518	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALOX15—atherosclerosis	2.01e-05	0.000518	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2e-05	0.000516	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.99e-05	0.000514	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCG5—atherosclerosis	1.99e-05	0.000512	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.98e-05	0.000512	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.98e-05	0.000511	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.96e-05	0.000506	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.94e-05	0.000501	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.94e-05	0.0005	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.93e-05	0.000499	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LPA—atherosclerosis	1.92e-05	0.000495	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.91e-05	0.000494	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.9e-05	0.000491	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SERPINE1—atherosclerosis	1.88e-05	0.000486	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—BGN—atherosclerosis	1.86e-05	0.000479	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.86e-05	0.000479	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.84e-05	0.000476	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA5—atherosclerosis	1.84e-05	0.000474	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.83e-05	0.000473	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.83e-05	0.000473	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA2—atherosclerosis	1.83e-05	0.000473	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.83e-05	0.000473	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.81e-05	0.000467	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.81e-05	0.000466	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.79e-05	0.000461	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.77e-05	0.000456	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.77e-05	0.000456	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.75e-05	0.000451	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LPA—atherosclerosis	1.75e-05	0.000451	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.73e-05	0.000447	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.73e-05	0.000446	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.72e-05	0.000443	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.71e-05	0.000441	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.71e-05	0.00044	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LIPC—atherosclerosis	1.71e-05	0.00044	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOC3—atherosclerosis	1.7e-05	0.000437	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—BGN—atherosclerosis	1.69e-05	0.000437	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LDLR—atherosclerosis	1.69e-05	0.000435	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.68e-05	0.000434	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA5—atherosclerosis	1.68e-05	0.000432	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CETP—atherosclerosis	1.65e-05	0.000425	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.63e-05	0.00042	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.61e-05	0.000416	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.6e-05	0.000411	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.58e-05	0.000408	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.58e-05	0.000407	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.58e-05	0.000407	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.58e-05	0.000407	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.56e-05	0.000402	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.54e-05	0.000396	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.53e-05	0.000395	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.52e-05	0.000393	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LIPC—atherosclerosis	1.52e-05	0.000393	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOC3—atherosclerosis	1.51e-05	0.00039	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LDLR—atherosclerosis	1.5e-05	0.000388	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.49e-05	0.000384	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CETP—atherosclerosis	1.47e-05	0.000379	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.44e-05	0.000371	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.41e-05	0.000363	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.4e-05	0.00036	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.39e-05	0.000358	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LIPC—atherosclerosis	1.39e-05	0.000358	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOC3—atherosclerosis	1.38e-05	0.000356	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LDLR—atherosclerosis	1.37e-05	0.000354	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.37e-05	0.000353	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.34e-05	0.000346	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CETP—atherosclerosis	1.34e-05	0.000346	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.33e-05	0.000343	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.33e-05	0.000342	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.28e-05	0.000331	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.25e-05	0.000322	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MAPK3—atherosclerosis	1.23e-05	0.000316	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.21e-05	0.000313	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.2e-05	0.000309	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.18e-05	0.000306	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.14e-05	0.000294	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.09e-05	0.000282	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOB—atherosclerosis	1.09e-05	0.000281	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.08e-05	0.000279	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTM1—atherosclerosis	1.06e-05	0.000274	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LPL—atherosclerosis	1.04e-05	0.000269	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.02e-05	0.000262	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GPX1—atherosclerosis	1.02e-05	0.000262	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CD36—atherosclerosis	9.89e-06	0.000255	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOB—atherosclerosis	9.73e-06	0.000251	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTM1—atherosclerosis	9.47e-06	0.000244	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTHFR—atherosclerosis	9.38e-06	0.000242	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LPL—atherosclerosis	9.3e-06	0.00024	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMOX1—atherosclerosis	9.27e-06	0.000239	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARA—atherosclerosis	9.2e-06	0.000237	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GPX1—atherosclerosis	9.07e-06	0.000234	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AGT—atherosclerosis	8.91e-06	0.00023	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOB—atherosclerosis	8.88e-06	0.000229	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CD36—atherosclerosis	8.83e-06	0.000228	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOE—atherosclerosis	8.73e-06	0.000225	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CAV1—atherosclerosis	8.65e-06	0.000223	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTM1—atherosclerosis	8.63e-06	0.000223	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA1—atherosclerosis	8.63e-06	0.000223	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LPL—atherosclerosis	8.48e-06	0.000219	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTHFR—atherosclerosis	8.37e-06	0.000216	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GPX1—atherosclerosis	8.27e-06	0.000213	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—atherosclerosis	8.26e-06	0.000213	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARA—atherosclerosis	8.21e-06	0.000212	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CD36—atherosclerosis	8.05e-06	0.000208	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AGT—atherosclerosis	7.95e-06	0.000205	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CG—atherosclerosis	7.88e-06	0.000203	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOE—atherosclerosis	7.79e-06	0.000201	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CAV1—atherosclerosis	7.72e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA1—atherosclerosis	7.7e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTHFR—atherosclerosis	7.63e-06	0.000197	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARG—atherosclerosis	7.6e-06	0.000196	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARA—atherosclerosis	7.49e-06	0.000193	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—INS—atherosclerosis	7.46e-06	0.000192	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AGT—atherosclerosis	7.25e-06	0.000187	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOE—atherosclerosis	7.1e-06	0.000183	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CAV1—atherosclerosis	7.04e-06	0.000182	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CG—atherosclerosis	7.03e-06	0.000181	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA1—atherosclerosis	7.02e-06	0.000181	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—atherosclerosis	6.84e-06	0.000176	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARG—atherosclerosis	6.79e-06	0.000175	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—INS—atherosclerosis	6.66e-06	0.000172	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NOS3—atherosclerosis	6.54e-06	0.000169	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.41e-06	0.000165	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARG—atherosclerosis	6.19e-06	0.00016	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—atherosclerosis	6.1e-06	0.000157	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—INS—atherosclerosis	6.07e-06	0.000157	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—atherosclerosis	5.98e-06	0.000154	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NOS3—atherosclerosis	5.84e-06	0.000151	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—atherosclerosis	5.56e-06	0.000144	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.34e-06	0.000138	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NOS3—atherosclerosis	5.32e-06	0.000137	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.87e-06	0.000126	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—atherosclerosis	3.01e-06	7.75e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—atherosclerosis	2.68e-06	6.92e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—atherosclerosis	2.45e-06	6.31e-05	CbGpPWpGaD
